Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merz Pharma Gains Radiesse Dermal Filler Via $253 Mil. BioForm Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Merz Pharma Group will round out its aesthetic product offerings by adding the Radiesse wrinkle filler device through its $253 million acquisition of BioForm Medical, announced Jan. 4

You may also be interested in...



New Products In Brief

Merz Aesthetics’ Belotero Balance dermal filler; Gore’s Conformable Gore TAG for thoracic aortic aneurysms; Maquet’s Cardiosave intra-aortic balloon pump. More new products.

Galderma Jumps Into Dermal Filler Device Market With Q-Med Offer

Dermatology drug maker Galderma will be able to offer Q-Med’s Restylane dermal filler device alongside its Azzalure botulinum toxin for wrinkle treatment after acquiring Q-Med for up to $1.1 billion.

Galderma Jumps Into Dermal Filler Device Market With Q-Med Offer

Dermatology drug maker Galderma will be able to offer Q-Med’s Restylane dermal filler device alongside its Azzalure botulinum toxin for wrinkle treatment after acquiring Q-Med for up to $1.1 billion.

Related Content

Topics

UsernamePublicRestriction

Register

MT028359

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel